CVE:NVH Novoheart (NVH) Stock Price, News & Analysis → The Gold Grab of the Century (From Colonial Metals) (Ad) Free NVH Stock Alerts C$0.53 +0.01 (+1.92%) (As of 11/20/2020) Add Compare Share Share Today's RangeC$0.52▼C$0.5350-Day RangeC$0.53▼C$0.5352-Week RangeC$0.26▼C$0.72Volume23,066 shsAverage Volume33,593 shsMarket CapitalizationC$99.98 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Novoheart alerts: Email Address Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << About NovoheartNovoheart Holdings Inc. operates as a stem cell biotechnology company in the United States. The company offers an array of next-generation human heart tissue prototypes. It provides MyHeart platform products, including human pluripotent stem cell-derived cardiomyocytes, human ventricular cardiac anisotropic sheet assays, and human ventricular cardiac tissue strips assays. The company also offers screening and phenotyping services; and consultation services, including mapping and designing preclinical studies that involve human embryonic or induced pluripotent stem cell-derived cardiomyocytes, prototyping custom bioreactor designs, and developing custom software for streamlining of screening platforms and analysis of acquired data. Novoheart Holdings Inc. has a collaboration with AstraZeneca to develop human-specific in vitro functional model of heart failure with preserved ejection fraction. The company is based in Vancouver, Canada.Read More NVH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NVH Stock News HeadlinesJune 12, 2023 | finance.yahoo.com067570.KQ - NVH Korea Inc.February 21, 2023 | uk.investing.comNVH Korea Inc (067570)April 25, 2024 | WealthPress (Ad)It’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. July 22, 2021 | investing.comNovoheart Holdings Inc (NVH)See More Headlines Receive NVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novoheart and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:NVH CUSIPN/A CIKN/A Webwww.novoheart.com Phone604-398 3170FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio27.62 Current Ratio6.13 Quick Ratio6.05 Sales & Book Value Annual SalesC$423,500.00 Price / Sales236.08 Cash FlowC$0.07 per share Price / Cash Flow7.46 Book ValueC$0.12 per share Price / Book4.34Miscellaneous Outstanding Shares188,641,000Free FloatN/AMarket CapC$99.98 million OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Ronald Li B.Sc. (Hons) (Age 49)Ph.D., Scientific Co-Founder, CEO & Director Comp: $295.17kDr. Camie Chan B.S. (Age 46)B.Sc. (Hons), M.Sc., Ph.D., Interim CFO, COO, Corp. Sec. & Director Comp: $312.03kProf. Kevin Costa B.S. (Age 54)Ph.D., Chief Scientific Officer & Scientific Co-Founder Prof. Michelle KhineScientific Co-Founder & Member of Scientific Advisory BoardKey Competitors138267 (COM.TO)TSE:COMScythian BiosciencesCVE:SCYBOncolytics BiotechTSE:ONCIntelGenx TechnologiesCVE:IGXTheratechnologiesTSE:THView All Competitors NVH Stock Analysis - Frequently Asked Questions How have NVH shares performed in 2024? Novoheart's stock was trading at C$0.53 at the start of the year. Since then, NVH shares have increased by 0.0% and is now trading at C$0.53. View the best growth stocks for 2024 here. What other stocks do shareholders of Novoheart own? Based on aggregate information from My MarketBeat watchlists, some companies that other Novoheart investors own include Invitae (NVTA) and Natera (NTRA). How do I buy shares of Novoheart? Shares of NVH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:NVH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novoheart Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.